Peter H. Schur

Active 1964–2021

Also published as
PETER H. SCHUR
74
Papers
19,111
Citations
70
h-index
74
i10-index

Citations

Citations per year for Peter H. Schur1967: 9 citations1968: 19 citations1969: 19 citations1970: 22 citations1971: 47 citations1972: 46 citations1973: 55 citations1974: 67 citations1975: 43 citations1976: 57 citations1977: 42 citations1978: 45 citations1979: 52 citations1980: 49 citations1981: 23 citations1982: 39 citations1983: 45 citations1984: 59 citations1985: 50 citations1986: 51 citations1987: 38 citations1988: 47 citations1989: 52 citations1990: 59 citations1991: 40 citations1992: 51 citations1993: 38 citations1994: 47 citations1995: 57 citations1996: 63 citations1997: 64 citations1998: 78 citations1999: 107 citations2000: 89 citations2001: 104 citations2002: 100 citations2003: 97 citations2004: 121 citations2005: 111 citations2006: 94 citations2007: 107 citations2008: 99 citations2009: 123 citations2010: 113 citations2011: 88 citations2012: 89 citations2013: 109 citations2014: 76 citations2015: 84 citations2016: 77 citations2017: 55 citations2018: 66 citations2019: 231 citations2020: 201 citations2021: 177 citations2022: 117 citations2023: 76 citations2024: 112 citations2025: 36 citations2026: 1 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,780 citing papers, 33.5% of this breakdownUnited Kingdom: 357 citing papers, 6.7% of this breakdownChina: 293 citing papers, 5.5% of this breakdownCanada: 244 citing papers, 4.6% of this breakdownItaly: 215 citing papers, 4.1% of this breakdownGermany: 197 citing papers, 3.7% of this breakdownFrance: 182 citing papers, 3.4% of this breakdownNetherlands: 169 citing papers, 3.2% of this breakdownJapan: 146 citing papers, 2.8% of this breakdownSweden: 140 citing papers, 2.6% of this breakdownSpain: 118 citing papers, 2.2% of this breakdownAustralia: 108 citing papers, 2% of this breakdown
0%33.5%Other 25.7%

Fields

  • Medicine71.2%
  • Immunology and Microbiology13.6%
  • Biochemistry, Genetics and Molecular Biology9.6%
  • Economics, Econometrics and Finance0.9%
  • Computer Science0.7%
  • Neuroscience0.7%
  • Other3.3%

Topics

  • Systemic Lupus Erythematosus Research17.5%
  • Monoclonal and Polyclonal Antibodies Research5.4%
  • T-cell and B-cell Immunology5.4%
  • Rheumatoid Arthritis Research and Therapies4.7%
  • Immune Cell Function and Interaction2.4%
  • Systemic Sclerosis and Related Diseases2.2%
  • Other62.4%

Coauthors

All papers

Open in search
  1. Derivation of the sledai. A disease activity index for lupus patients

    Authors: , , , , , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 1992 cited by 4,573

  2. Deoxybonucleic acid (DNA) and antibodies to DNA in the serum of patients with systemic lupus erythematosus.

    Authors: , , , - Journal of Clinical Investigation 1966 cited by 834

  3. ANA screening: an old test with new recommendations

    Authors: , - Annals of the Rheumatic Diseases 2010 cited by 544

  4. Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease.

    Authors: , , , , , - Journal of Clinical Investigation 1996 cited by 471

  5. Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus

    Authors: , , , - Arthritis & Rheumatism 1989 cited by 793

  6. Correlation between Serum IgG-2 Concentrations and the Antibody Response to Bacterial Polysaccharide Antigens

    Authors: , , , , - New England Journal of Medicine 1980 cited by 473

  7. Z-DNA-specific antibodies in human systemic lupus erythematosus.

    Authors: , , , , , , - Journal of Clinical Investigation 1983 cited by 132

  8. Elevated Anti–Citrullinated Protein Antibodies Prior to Rheumatoid Arthritis Diagnosis and Risks for Chronic Obstructive Pulmonary Disease or Asthma

    Authors: , , , , , , , , , , , , , - Arthritis Care & Research 2020 cited by 34

  9. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis

    Authors: , , , , , , , , , , , , , - Arthritis Research & Therapy 2019 cited by 38

  10. Evidence‐based guidelines for the use of immunologic tests: Antinuclear antibody testing

    Authors: , , - Arthritis Care & Research 2002 cited by 509

  11. Immunologic Factors and Clinical Activity in Systemic Lupus Erythematosus

    Authors: , - New England Journal of Medicine 1968 cited by 596

  12. Proteins Phosphorylated during Stress-induced Apoptosis Are Common Targets for Autoantibody Production in Patients with Systemic Lupus Erythematosus

    Authors: , , , - The Journal of Experimental Medicine 1997 cited by 224

  13. Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non–rheumatoid arthritis controls

    Authors: , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2012 cited by 101

  14. The American college of rheumatology response criteria for proliferative and membranous renal disease in systemic lupus erythematosus clinical trials

    Authors: , , , , , , , , , , , , , , , , , - Arthritis & Rheumatism 2006 cited by 262

  15. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria.

    Authors: , , , , , , , - Journal of Clinical Investigation 1985 cited by 176

  16. EFFECTS OF AEROBIC CONDITIONING IN LUPUS FATIGUE: A PILOT STUDY

    Authors: , , , , , , , - Lara D. Veeken 1989 cited by 137

  17. Human α-Fetoprotein

    Authors: , , , - Journal of Biological Chemistry 1972 cited by 131

  18. Guidelines for immunologic laboratory testing in the rheumatic diseases: Anti‐Sm and anti‐RNP antibody tests

    Authors: , , - Arthritis Care & Research 2004 cited by 99

  19. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity

    Authors: , , , , , , , , , , , - Arthritis & Rheumatism 2010 cited by 75

  20. Evaluation of Three Commercial and Two Non-Commercial Immunoassays for the Detection of Prior Infection to SARS-CoV-2

    Authors: , , , , , , , , , , , , , , , , - The Journal of Applied Laboratory Medicine 2021 cited by 21

  21. IMMUNOLOGICAL STUDIES CONCERNING THE NEPHRITIS OF SYSTEMIC LUPUS ERYTHEMATOSUS

    Authors: , , - The Journal of Experimental Medicine 1967 cited by 882

  22. Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial

    Authors: , , , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 1986 cited by 362

  23. Decreased expression of the C3b/C4b receptor (CR1) and the C3d receptor (CR2) on B lymphocytes and of CR1 on neutrophils of patients with systemic lupus erythematosus

    Authors: , , , - Arthritis & Rheumatism 1986 cited by 185

  24. The psychosocial impact of systemic lupus erythematosus and rheumatoid arthritis

    Authors: , , , , , , , - Arthritis & Rheumatism 1984 cited by 184